Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: Results from the International Diabetes MILES Study

Nefs, G; Hendrieckx, C; Reddy, P; Browne, JL; Bot, M; Dixon, J; Kyrios, M; Speight, J; Pouwer, F

Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: Results from the International Diabetes MILES Study

Nefs, G Hendrieckx, C Reddy, P

Browne, JL Bot, M Dixon, J Kyrios, M Speight, J Pouwer, F

Permalink

Publication Type:: Journal Article
Citation:: Journal of Diabetes and its Complications, 2019, 33 (8), pp. 523 - 529
Issue Date:: 2019-08-01

Closed Access

	Filename	Description	Size
	1-s2.0-S1056872719302235-main.pdf	Published Version	374.51 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Nefs, G	en_US
dc.contributor.author	Hendrieckx, C	en_US
dc.contributor.author	Reddy, P https://orcid.org/0000-0002-0709-9352	en_US
dc.contributor.author	Browne, JL	en_US
dc.contributor.author	Bot, M	en_US
dc.contributor.author	Dixon, J	en_US
dc.contributor.author	Kyrios, M	en_US
dc.contributor.author	Speight, J	en_US
dc.contributor.author	Pouwer, F	en_US
dc.date.available	2019-04-22	en_US
dc.date.issued	2019-08-01	en_US
dc.identifier.citation	Journal of Diabetes and its Complications, 2019, 33 (8), pp. 523 - 529	en_US
dc.identifier.issn	1056-8727	en_US
dc.identifier.uri	http://hdl.handle.net/10453/138441
dc.description.abstract	© 2019 Elsevier Inc. Aims: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type. Methods: Cross-sectional self-report data of 6590 adults with diabetes (42% type 1; 58% type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10. Results: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9% and symptoms of anxiety alone in 2%; symptoms of depression alone were present in 8% of adults with type 1 diabetes and 11% with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone. Conclusions: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.	en_US
dc.relation.ispartof	Journal of Diabetes and its Complications	en_US
dc.relation.isbasedon	10.1016/j.jdiacomp.2019.04.013	en_US
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.classification	Endocrinology & Metabolism	en_US
dc.title	Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: Results from the International Diabetes MILES Study	en_US
dc.type	Journal Article
utslib.citation.volume	8	en_US
utslib.citation.volume	33	en_US
utslib.for	111706 Epidemiology	en_US
utslib.for	1103 Clinical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Faculty of Business/Management Discipline
utslib.copyright.status	closed_access	*
pubs.issue	8	en_US
pubs.publication-status	Published	en_US
pubs.volume	33	en_US

Abstract:

© 2019 Elsevier Inc. Aims: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type. Methods: Cross-sectional self-report data of 6590 adults with diabetes (42% type 1; 58% type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10. Results: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9% and symptoms of anxiety alone in 2%; symptoms of depression alone were present in 8% of adults with type 1 diabetes and 11% with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone. Conclusions: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/138441